Direct renin inhibitor, aliskiren, attenuates the progression of non-alcoholic steatohepatitis in the rat model
Author:
Affiliation:
1. Third Department of Internal Medicine; Nara Medical University; Nara Japan
Publisher
Wiley
Subject
Infectious Diseases,Hepatology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/hepr.12081/fullpdf
Reference51 articles.
1. Nonalcoholic fatty liver disease;Angulo;N Engl J Med,2002
2. Clinical and pathological progression of non-alcoholic steatohepatitis to hepatocellular carcinoma;Yasui;Hepatol Res,2012
3. Impact of insulin resistance on the progression of chronic liver diseases;Kaji;Int J Mol Med,2008
4. Relationship between adipose tissue insulin resistance and liver histology in NASH: a PIVENS follow-up study;Bell;Hepatology,2012
5. Association between diabetes, family history of diabetes and risk of nonalcoholic steatohepatitis and fibrosis;Loomba;Hepatology,2012
Cited by 23 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Insight into the hepatoprotective, hypolipidemic, and antidiabetic impacts of aliskiren in streptozotocin-induced diabetic liver disease in mice;Diabetology & Metabolic Syndrome;2022-10-31
2. Long-Term Effects of Rifaximin on Patients with Hepatic Encephalopathy: Its Possible Effects on the Improvement in the Blood Ammonia Concentration Levels, Hepatic Spare Ability and Refractory Ascites;Medicina;2022-09-14
3. (Pro)renin receptor inhibition attenuated liver steatosis, inflammation, and fibrosis in mice with steatohepatitis;The FASEB Journal;2022-09-05
4. Combined Treatment with Sodium-Glucose Cotransporter-2 Inhibitor (Canagliflozin) and Dipeptidyl Peptidase-4 Inhibitor (Teneligliptin) Alleviates NASH Progression in A Non-Diabetic Rat Model of Steatohepatitis;International Journal of Molecular Sciences;2020-03-21
5. The use of aliskiren as an antifibrotic drug in experimental models: A systematic review;Drug Development Research;2019-10-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3